Daniel S. Lorrain

Companies

• Contineum Therapeutics, Inc.Chief Scientific Officer Apr 4, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CTContineum Therapeutics, Inc. CTNM145,312 shares²$1.0M at $7.08Jul 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 9, 2026Sold 25 shares at $16.00 of Contineum Therapeutics, Inc.²
• Jul 9, 2026Exercised options 25 shares at $1.01 of Contineum Therapeutics, Inc.²
• Jul 8, 2026Sold 1,015 shares at $16.00 of Contineum Therapeutics, Inc.²
• Jul 8, 2026Exercised options 1,015 shares at $1.01 of Contineum Therapeutics, Inc.²
• Jul 1, 2026Sold 2,501 shares at $16.24 of Contineum Therapeutics, Inc.³
• Jul 1, 2026Sold 5,852 shares at $15.67 of Contineum Therapeutics, Inc.³
• Jul 1, 2026Exercised options 4,183 shares at $1.01 of Contineum Therapeutics, Inc.³
• Jun 30, 2026Sold 28,826 shares at $16.04 of Contineum Therapeutics, Inc.³
• Jun 30, 2026Exercised options 28,826 shares at $1.01 of Contineum Therapeutics, Inc.³
• Jun 1, 2026Sold 4,170 shares at $13.16 of Contineum Therapeutics, Inc.⁴
• May 1, 2026Sold 300 shares at $13.84 of Contineum Therapeutics, Inc.⁵
• May 1, 2026Sold 3,870 shares at $13.06 of Contineum Therapeutics, Inc.⁵
• Apr 6, 2026Sold 4,170 shares at $13.43 of Contineum Therapeutics, Inc.⁶
• Mar 2, 2026Sold 4,170 shares at $15.01 of Contineum Therapeutics, Inc.⁷
• Feb 25, 2026Sold 3,824 shares at $16.01 of Contineum Therapeutics, Inc.⁸
• Feb 25, 2026Exercised options 3,824 shares at $1.01 of Contineum Therapeutics, Inc.⁸
• Feb 24, 2026Sold 4,300 shares at $16.03 of Contineum Therapeutics, Inc.⁸
• Feb 24, 2026Exercised options 4,300 shares at $1.01 of Contineum Therapeutics, Inc.⁸
• Feb 19, 2026Sold 100 shares at $16.00 of Contineum Therapeutics, Inc.⁹
• Feb 19, 2026Exercised options 100 shares at $1.01 of Contineum Therapeutics, Inc.⁹
• Feb 11, 2026Sold 400 shares at $16.00 of Contineum Therapeutics, Inc.¹⁰
• Feb 11, 2026Exercised options 400 shares at $1.01 of Contineum Therapeutics, Inc.¹⁰
• Feb 3, 2026Sold 1,170 shares at $15.25 of Contineum Therapeutics, Inc.¹¹
• Feb 3, 2026Sold 3,000 shares at $14.82 of Contineum Therapeutics, Inc.¹¹
• Jan 5, 2026Sold 500 shares at $11.13 of Contineum Therapeutics, Inc.¹²